US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

31.30

-0.1066-0.34%

Post-market: 31.26-0.0434-0.14%19:30 EDT

Volume:2K

Turnover:77.92K

Market Cap:50.83M

PE:- -

High:31.42

Open:31.22

Low:31.20

Close:31.41

52wk High:32.89

52wk Low:23.48

Shares:1.62M

Float Shares:1.62M

Volume Ratio:0.34

T/O Rate:0.15%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million

Thermo Fisher EVP Michael D. Shafer Disposes of 25,500 Common Shares Worth $15.3 Million Under 10b5-1 Plan

Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors

LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20

10x Genomics is Maintained at Overweight by Stephens & Co.

10x Genomics (TXG) Gets a Buy from Stephens

Thermo Fisher Completes Sale of Microbiology Business to Astorg for $1.08 Billion

Thermo Fisher Scientific Completes Sale of Its Microbiology Business to Astorg

THOMSON REUTERS

Danaher (DHR) Could Be 9% Undervalued Following Its CEO Transition News

Simply Wall St.

10x Genomics, Inc. : Stephens Raises Target Price to $65 from $50

THOMSON REUTERS

Achieve Life Sciences Q2 Loss Widens on Warrant Liabilities

908 Devices Q2 Revenue Beats on Increased VipIR Sales

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)

Revvity Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

How Investors Are Reacting To LifeStance Health Group (LFST) Profit Return, Guidance Hike, And New Buyback

Simply Wall St.

Mesa Labs Q1 Revenue Rises as Calibration, Biopharma Units Grow

LifeStance rises 13.2%

10x Genomics Inc : Canaccord Genuity Raises Target Price to $60 from $50

THOMSON REUTERS

XPO Names Jonas Svedlund Chief Legal Officer

10x Genomics price target raised to $47 from $42 at Piper Sandler

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/FMED/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":31.3034,"timestamp":1789502400000,"preClose":31.41,"halted":0,"volume":2488,"hourTrading":{"tag":"盘后","latestPrice":31.26,"preClose":31.3034,"latestTime":"19:30 EDT","volume":7,"amount":219.1238,"timestamp":1789515005451,"change":-0.0434,"changeRate":-0.001386,"amplitude":0},"delay":0,"changeRate":-0.003393823623049992,"floatShares":1623806,"shares":1623806,"eps":0,"marketStatus":"Not Yet Opened","change":-0.1066,"latestTime":"09-15 16:00:00 EDT","open":31.22,"high":31.42,"low":31.2001,"amount":77919.318352,"amplitude":0.007001,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":31.41,"sharesOutstanding":2323806,"nav":30.831238,"aum":50953312.669446,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.26,"preClose":31.3034,"latestTime":"19:30 EDT","volume":7,"amount":219.1238,"timestamp":1789515005451,"change":-0.0434,"changeRate":-0.001386,"amplitude":0},"volumeRatio":0.344799,"impliedVol":0.0711,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":1623806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.344799,"shares":1623806,"dividePrice":0,"high":31.42,"amplitude":0.007001,"preClose":31.41,"low":31.2001,"week52Low":23.48,"pbRate":"--","week52High":32.8877,"institutionHeld":0,"latestPrice":31.3034,"eps":0,"divideRate":0,"volume":2488,"delay":0,"ttmEps":0,"open":31.22,"prevYearClose":27.05,"prevWeekClose":31,"prevMonthClose":31.775,"prevQuarterClose":28.525,"fiveDayClose":31.542,"twentyDayClose":30.5871,"sixtyDayClose":26.1028},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659208162","title":"10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659208162","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659208162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:13","pubTimestamp":1786651992,"startTime":"0","endTime":"0","summary":"10x Genomics director John R. Stuelpnagel sells 20,000 shares worth $1.15 million10x Genomics director John R. Stuelpnagel sold 20,000 Class A common shares on Aug. 11, 2026.Sales priced at USD 57.58 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLZd8PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4121","LU1861558580.USD","BK4548","LU1861559042.SGD","TXG","FMED","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164067","title":"Thermo Fisher EVP Michael D. Shafer Disposes of 25,500 Common Shares Worth $15.3 Million Under 10b5-1 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164067","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164067?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:02","pubTimestamp":1786651375,"startTime":"0","endTime":"0","summary":"Thermo Fisher EVP Michael D. Shafer disposes of 25,500 common shares worth $15.3 million under 10b5-1 planThermo Fisher Executive Vice President Michael D. Shafer sold 25,500 shares on Aug. 11 at USD ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2cbkgB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Thermo Fisher EVP Michael D. Shafer Disposes of 25,500 Common Shares Worth $15.3 Million Under 10b5-1 Plan","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMO","IE00BKPKM429.USD","LU1670627923.USD","LU1720051017.SGD","LU1983299246.USD","LU0266013472.USD","LU1633808545.USD","IE00B19Z9505.USD","LU0432979614.USD","BK4533","LU0310800379.SGD","LU1923622291.USD","LU2089984988.USD","LU2764263203.CNY","LU0234572021.USD","IE00BQXX3D17.EUR","LU1267930573.SGD","HRTS","GNMX","LU0320765489.SGD","LU0029864427.USD","FMED","LU0708994859.HKD","LU1988902786.USD","TMED","LU2125909759.SGD","LU0342679015.USD","LU0345770308.USD","BK4548","LU2211815571.USD","IE00BQXX3C00.GBP","LU2125909916.SGD","LU2357305700.SGD","LU1791710582.SGD","LU2298321311.HKD","LU1803068623.USD","LU2125909247.SGD","LU2041044095.USD","LU0096362180.USD","BK4588","IE00BJT1NW94.SGD","LU1057294990.SGD","BK4585","LU0557290698.USD","LU1670628061.USD","LU2764263039.SGD","IE00B19Z8W00.USD","LU0122379950.USD","LU2063271972.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659093166","title":"Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2659093166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659093166?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:31","pubTimestamp":1786638686,"startTime":"0","endTime":"0","summary":"Argenx ($ARGX) announced an update on their ongoing clinical study. The new argenx study focuses on empasiprubart in adults with multifocal motor n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenx-advances-empasiprubart-in-rare-nerve-disorder-adding-long-term-upside-for-argx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenx-advances-empasiprubart-in-rare-nerve-disorder-adding-long-term-upside-for-argx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","LU2324357040.USD","ARGX","BK4211","FMED","IE00BJJMRZ35.SGD","BK4139","LU0320765992.SGD","BK4505","LU0889565916.HKD","TBXU","LU1983260115.SGD","ISBC","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4585","LU0109394709.USD","LU0823416689.USD","BK4588","IE0002141913.USD","IBB","IE00BJT1NW94.SGD","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188032","title":"LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188032","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188032?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:00","pubTimestamp":1786568426,"startTime":"0","endTime":"0","summary":"LifeStance COO Lisa K. Miller disposes of 47,912 common shares worth $519,245.20LifeStance Health COO Lisa K. Miller sold 47,912 common shares on Aug. 10 at USD 10.85.Direct holding fell to 281,289 sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL98VmhP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFST","BK4535","FMED","BK4196","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659838901","title":"10x Genomics is Maintained at Overweight by Stephens & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659838901","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659838901?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:31","pubTimestamp":1786552260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TXG/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMED","LU1861559042.SGD","LU1861558580.USD","BK4585","BK4548","ARKG","BK4588","BK4121","TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908472","title":"10x Genomics (TXG) Gets a Buy from Stephens","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908472?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:36","pubTimestamp":1786541791,"startTime":"0","endTime":"0","summary":"Stephens analyst reiterated a Buy rating on 10x Genomics today and set a price target of $65.00. In addition to Stephens, 10x Genomics also receive...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/10x-genomics-txg-gets-a-buy-from-stephens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/10x-genomics-txg-gets-a-buy-from-stephens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXG","BK4585","BK4588","LU1861558580.USD","BK4548","ARKG","FMED","BK4121","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972674","title":"Thermo Fisher Completes Sale of Microbiology Business to Astorg for $1.08 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972674","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972674?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:03","pubTimestamp":1786536209,"startTime":"0","endTime":"0","summary":"Thermo Fisher completes sale of microbiology business to Astorg for $1.08 billionThermo Fisher completed the sale of its microbiology business to private equity firm Astorg for about $1.075 billion.Co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL5b7x1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","FMED","LU2125910179.SGD","LU1057294990.SGD","LU0266013472.USD","LU0114720955.EUR","LU1988902786.USD","LU2112291526.USD","LU2433249047.HKD","BK4548","LU0316494557.USD","LU0432979614.USD","LU1267930573.SGD","LU1670628061.USD","GB00BDT5M118.USD","LU0011850046.USD","LU2764262908.HKD","GNMX","LU2125910336.SGD","LU2764263039.SGD","IE0034235188.USD","LU1720051017.SGD","LU1280957306.USD","LU0096362180.USD","LU0128525929.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","BK4566","LU1623119135.USD","LU2125909916.SGD","IE00BKPKM429.USD","BK4534","LU0708994859.HKD","LU2720916845.USD","TMO","LU1064131342.USD","LU0345770993.USD","IE0009355771.USD","IE00BQXX3D17.EUR","LU0528227936.USD","TMED","BK4581","HRTS","LU0882574055.USD","LU1791710400.SGD","LU1712237335.SGD","LU1815333072.USD","LU2063271972.USD","LU1923622291.USD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658594972","title":"Thermo Fisher Scientific Completes Sale of Its Microbiology Business to Astorg","url":"https://stock-news.laohu8.com/highlight/detail?id=2658594972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658594972?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA50LBGD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1854104046.USD","IE00B19Z8W00.USD","LU0316494557.USD","LU0234572021.USD","LU0708994859.HKD","BK4121","LU1267930573.SGD","LU2764262908.HKD","LU0011850046.USD","LU1057294990.SGD","IE00B19Z8X17.USD","IE00BQXX3F31.USD","LU2433249047.HKD","IE00BFTCPJ56.SGD","TMO","FMED","LU2125910336.SGD","HRTS","LU1280957306.USD","GB00BDT5M118.USD","LU2764263039.SGD","LU0345770308.USD","IE0034235188.USD","BK4566","LU0096362180.USD","LU1720051108.HKD","LU1988902786.USD","LU2298321311.HKD","TMED","IE00B4R5TH58.HKD","LU1712237335.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","LU0061474960.USD","LU0122379950.USD","LU1923621640.USD","LU2092937221.SGD","LU0432979614.USD","LU2125909916.SGD","GNMX","LU2357305700.SGD","LU1720051017.SGD","BK4534","LU2211814178.USD","LU1023059063.AUD","BK4533","BK4588","IE0009355771.USD","IE00B2B36J28.USD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658973600","title":"Danaher (DHR) Could Be 9% Undervalued Following Its CEO Transition News","url":"https://stock-news.laohu8.com/highlight/detail?id=2658973600","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658973600?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:34","pubTimestamp":1786523643,"startTime":"0","endTime":"0","summary":"Danaher (DHR) is back in focus after announcing that Julie Sawyer Montgomery will become CEO and President on October 1, 2026, with outgoing CEO Rainer Blair staying on temporarily as senior advisor.\nSee our latest analysis for Danaher.\nAgainst the leadership news backdrop, Danaher's share price has risen over the past week and quarter, with a 7 day share price return of 6.5% and a 90 day share price return of 25.0%. However, the year to date share price return is down 10.0% and the 5 year...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/265621-main-header/1756203226349","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/265621-main-header/1756203226349"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/danaher-dhr-could-be-9-undervalued-following-its-ceo-transit","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/danaher-dhr-could-be-9-undervalued-following-its-ceo-transit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2023250504.SGD","LU0689472784.USD","LU0114720955.EUR","LU0511384066.AUD","LU2112291526.USD","DHR","LU0187121727.USD","BK4504","SG9999001176.SGD","LU2063271972.USD","LU0320765059.SGD","LU2125910336.SGD","FMED","BK4581","LU0820561818.USD","SGXZ57979304.SGD","LU0289960550.SGD","LU0122379950.USD","LU0882574055.USD","LU2106854487.HKD","LU0107464264.USD","LU1061106388.HKD","IE00BQXX3D17.EUR","LU1791710582.SGD","LU0097036916.USD","LU0312595415.SGD","LU2265009873.SGD","BK4588","IE000M9KFDE8.USD","BK4533","DHR.AU","IE00BQXX3F31.USD","BK4121","LU0289739343.SGD","LU1804176565.USD","LU1917777945.USD","LU2125909247.SGD","IE0004445239.USD","SG9999013999.USD","IE00BZ1G4Q59.USD","LU1974910355.USD","SG9999004303.SGD","LU0175139822.USD","IE00BQXX3C00.GBP","LU2125909593.SGD","SG9999001176.USD","LU1791710400.SGD","LU0390134368.USD","LU1551013342.USD","LU1923622614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658923857","title":"10x Genomics, Inc. : Stephens Raises Target Price to $65 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2658923857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658923857?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:57","pubTimestamp":1786507046,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44903W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FMED","LU1861559042.SGD","BK4588","ARKG","BK4585","BK4121","TXG","BK4548","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658791868","title":"Achieve Life Sciences Q2 Loss Widens on Warrant Liabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2658791868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658791868?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:39","pubTimestamp":1786451965,"startTime":"0","endTime":"0","summary":"Achieve Life Sciences Q2 loss widens on warrant liabilitiesOverviewUS specialty pharma firm's Q2 net loss and loss per share missed analyst expectationsQ2 net loss includes $48.7 mln non-cash charge f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0342679015.USD","IE0009355771.USD","LU1854104046.USD","LU1923621640.USD","LU1153585028.USD","TMED","LU0208291251.USD","LU0957791311.USD","LBRX","LU1057294990.SGD","LU2764262908.HKD","IE00BQXX3C00.GBP","LU2764263039.SGD","GNMX","LU0234572021.USD","LU1720051108.HKD","LU2041044095.USD","IE00BQXX3D17.EUR","ACHV","HRTS","LU2264538146.SGD","TMO","BK4585","IE00B1BXHZ80.USD","LU1623119135.USD","LU1712237335.SGD","BK4548","LU2063271972.USD","LU0882574055.USD","LU0122379950.USD","LU1815333072.USD","IE00B19Z8W00.USD","LU1803068623.USD","BK4121","FMED","LU1983299246.USD","SCYX","IE0002141913.USD","LU0528227936.USD","LU1633808545.USD","IE00BJJMRZ35.SGD","LU2125909247.SGD","LU1670628061.USD","LU1061106388.HKD","LU0640476718.USD","LU0823416689.USD","LU2468319806.SGD","LU2543165471.USD","LU0096362180.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992905","title":"908 Devices Q2 Revenue Beats on Increased VipIR Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992905","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992905?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:16","pubTimestamp":1786447007,"startTime":"0","endTime":"0","summary":"908 Devices Q2 revenue beats on increased VipIR salesOverviewU.S. handheld chemical analysis tool maker's Q2 revenue grew 23%, beating analyst expectationsNet loss for Q2 widened, missing analyst esti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","LU0528227936.USD","LU0557290698.USD","LU2298321311.HKD","LU0345770308.USD","LU0208291251.USD","GNMX","FMED","LU0316494557.USD","LU1670627923.USD","LU1983299246.USD","LU2125909759.SGD","TMED","IE0002141913.USD","IE0034235188.USD","LU1548497426.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","IE00BQXX3F31.USD","LU2125910179.SGD","LU1854104046.USD","LU0011850046.USD","IE00BQXX3C00.GBP","MLAB","LU0882574055.USD","LU0823416689.USD","IE00B19Z8W00.USD","LU0234572021.USD","HRTS","LU0061474960.USD","BK4566","LU2433249047.HKD","BK4121","LU1061106388.HKD","LU2211814178.USD","IE00B1BXHZ80.USD","LU0320765489.SGD","BK4548","LU2764263039.SGD","BK4535","MASS","IE00BJT1NW94.SGD","LU0432979614.USD","LU1280957306.USD","LU1064131342.USD","LU0096362180.USD","LU2764262908.HKD","LU1923621640.USD","LU2720916845.USD","TMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954159","title":"Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954159?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:50","pubTimestamp":1786438213,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaV...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hims-hers-health-hims-lifestance-health-group-lfst-and-davita-dva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hims-hers-health-hims-lifestance-health-group-lfst-and-davita-dva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4196","HEAL","HMYY","DVA","BK4585","HIMY","LFST","THNR","BK4559","HIYY","HIMS","BK4588","GLAM","FMED","HIMZ","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658844952","title":"Revvity Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2658844952","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658844952?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:16","pubTimestamp":1786396560,"startTime":"0","endTime":"0","summary":"DJ Revvity Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  rallied 1.19% to $116.02 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.06% to 7,753.11 and Dow Jones Industrial Average  falling 0.11% to 53,975.98.This was the stock's second consecutive day of gains.Revvity Inc. closed 1.93% short of its 52-week high of $118.30, which the company achieved on January 22nd.The stock underperformed when compared to some of its competitors Monday, as Danaher Corp.  rose 2.25% to $209.37, IDEXX Laboratories Inc.  rose 1.55% to $595.76, and Agilent Technologies Inc.  rose 1.88% to $148.72.Trading volume  remained 301,209 below its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1291159041.SGD","PAWZ","LU0289961442.SGD","SG9999013999.USD","LU0107464264.USD","LU0690374615.EUR","LU0320765059.SGD","LU1941712348.USD","LU2413666426.HKD","A","LU2125909593.SGD","LU2211814178.USD","IE00BQXX3F31.USD","LU0689472784.USD","BK4082","LU1366333091.USD","IE00BQXX3D17.EUR","LU0511384066.AUD","LU0347712357.USD","LU0097036916.USD","LU1721429402.USD","LU2125909247.SGD","LU0432979614.USD","SGXZ23171101.USD","FMED","LU0345774631.USD","LU0820561909.HKD","LU1267930730.SGD","LU0289960550.SGD","LU2404859741.USD","LU0187121727.USD","LU2089279066.USD","IE000M9KFDE8.USD","LU0157215616.USD","LU2106854487.HKD","IE00B64QTZ34.USD","LU0345774391.USD","LU1721428933.USD","LU0175139822.USD","BK4567","DHR","BK4534","RVTY","IE00BQXX3C00.GBP","LU2023250504.SGD","LU1061106388.HKD","IE0004445239.USD","LU0528227936.USD","IDXX","LU2413666699.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952924","title":"How Investors Are Reacting To LifeStance Health Group (LFST) Profit Return, Guidance Hike, And New Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952924","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952924?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:25","pubTimestamp":1786393555,"startTime":"0","endTime":"0","summary":"LifeStance Health Group recently reported its second-quarter 2026 results, posting US$435.35 million in sales and returning to profitability, while also completing a buyback of 13,000,000 shares for US$97.19 million under a previously announced program and launching a new authorization of up to US$100 million in repurchases.\nAlongside raising both third-quarter and full-year 2026 revenue guidance, management pointed to clinician productivity gains, specialty service growth, and improved...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/how-investors-are-reacting-to-lifestance-health-group-lfst-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/how-investors-are-reacting-to-lifestance-health-group-lfst-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QTOC","BK4196","BK4211","ARTY","RGLO","GXDW","CHAT","DECU","AIPO","FEBU","AGIX","PMDE","ISBC","VGFPF","LFST","FMED","JOYT","BK4539","BK4535","VTHR","VOTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959654","title":"Mesa Labs Q1 Revenue Rises as Calibration, Biopharma Units Grow","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959654","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959654?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:12","pubTimestamp":1786392774,"startTime":"0","endTime":"0","summary":"Mesa Labs Q1 revenue rises as calibration, biopharma units growOverviewUS life science tools maker's fiscal Q1 revenue rose 1.0% year-over-yearAdjusted operating income excluding unusual items increas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470VC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791710582.SGD","IE0002141913.USD","IE00B19Z9505.USD","LU0557290698.USD","GB00BDT5M118.USD","TMO","TMED","LU1989771016.USD","LU0266013472.USD","HRTX","HRTS","MLAB","LU0957791311.USD","LU2125909759.SGD","LU2125910179.SGD","LU1023059063.AUD","LU2764263203.CNY","LU0345770993.USD","GNMX","LU2264538146.SGD","LU2468319806.SGD","QTRX","LU1923622291.USD","BK4548","LU1803068623.USD","LU2092937221.SGD","LU2764263039.SGD","FMED","LU2089984988.USD","LU1791710400.SGD","LU1548497426.USD","BK4566","BK4139","LU1064131342.USD","LU1057294990.SGD","LU2720916845.USD","IE00B19Z8W00.USD","LU2764262908.HKD","LU1670628061.USD","LU1815333072.USD","LU2357305700.SGD","LU1720051108.HKD","LU1923621640.USD","LU1988902786.USD","BK4121","BK4535","BK4534","LU2125909593.SGD","LU2125910336.SGD","LU2125909916.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658588509","title":"LifeStance rises 13.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658588509","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658588509?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:06","pubTimestamp":1786377964,"startTime":"0","endTime":"0","summary":"LifeStance (LFST) is up 13.2%, or $1.43 to $12.27. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lifestance-rises-13-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lifestance-rises-13-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4539","BK4196","LFST","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993450","title":"10x Genomics Inc : Canaccord Genuity Raises Target Price to $60 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993450","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993450?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:47","pubTimestamp":1786369626,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","BK4121","TXG","ARKG","FMED","BK4548","LU1861558580.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658933024","title":"XPO Names Jonas Svedlund Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933024","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658933024?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:45","pubTimestamp":1786362327,"startTime":"0","endTime":"0","summary":"XPO names Jonas Svedlund chief legal officerXPO appointed Jonas Svedlund as chief legal officer, effective immediately.He will lead the company’s legal and compliance functions, including corporate go","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL1Xjnw2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITA","HRTS","GNMX","LU1854103824.USD","NDAQ","LU1923621640.USD","PPA","TMED","LU0823416689.USD","LU0868494617.USD","BCDF","LU2125910336.SGD","LU2063271972.USD","BK4543","LU1366333091.USD","IE00BQXX3F31.USD","LU2468319806.SGD","LU0528227936.USD","XPO","LU1093756168.USD","TMO","XAR","LU2298321311.HKD","IE00BN0W2W23.USD","IE00BJT1NW94.SGD","UXI","LU1066051498.USD","NATO","LU0557290698.USD","LU1066053197.SGD","MISL","BK4232","DFEN","IE00BQXX3C00.GBP","TRUI","IE00BN0W2T93.GBP","LU1670628061.USD","GE","LU1989771016.USD","FMED","LU2089984988.USD","LU2764262908.HKD","LU1923622291.USD","LU2433249047.HKD","EXI","LU2125910179.SGD","LU2211814178.USD","LU1093756325.SGD","BK4585","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658388933","title":"10x Genomics price target raised to $47 from $42 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2658388933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658388933?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:20","pubTimestamp":1786360847,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on 10x Genomics (TXG) to $47 from $42 and keeps a Neutral rating on the shares following quarterly res...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/10x-genomics-price-target-raised-to-47-from-42-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/10x-genomics-price-target-raised-to-47-from-42-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ARKG","LU1861559042.SGD","BK4548","BK4588","BK4121","TXG","FMED","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}